STEVENSON, Md., April 29, 2018 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of purchasers of Colony NorthStar, Inc. (NYSE:CLNS) (“Colony NorthStar” or the “Company”) securities during the period between February 28, 2017 through March 1, 2018, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until June 5, 2018 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Colony NorthStar securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Colony NorthStar’s Healthcare and Investment Management segments were performing worse than reported.
According to the complaint, following a March 1, 2018 announcement of a goodwill impairment of $375 million attributable to the Investment Management segment and disappointing performance due to challenging industry conditions in healthcare, the value of Colony NorthStar shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Colony NorthStar securities purchased on or after February 28, 2017 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please contact Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven
Brower Piven, A Professional Corporation
1925 Old Valley Road
Stevenson, Maryland 21153
Telephone: 410-415-6616
[email protected]


Japan Earthquake Disrupts Auto and Chip Supply Chains
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
World game at war: why some European nations have threatened a World Cup boycott
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock 



